Literature DB >> 22656328

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Naga Chalasani1, Zobair Younossi, Joel E Lavine, Anna Mae Diehl, Elizabeth M Brunt, Kenneth Cusi, Michael Charlton, Arun J Sanyal.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22656328     DOI： 10.1053/j.gastro.2012.04.001

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  591 in total

1.  Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.

Authors:  Geraldine J Ooi; Paul R Burton; Arul Earnest; Cheryl Laurie; William W Kemp; Peter D Nottle; Catriona A McLean; Stuart K Roberts; Wendy A Brown
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

2.  Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.

Authors:  Daniel L Motola; Peter Caravan; Raymond T Chung; Bryan C Fuchs
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 3.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

4.  Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.

Authors:  Shingo Tanaka; Koji Miyanishi; Masayoshi Kobune; Yutaka Kawano; Toshifumi Hoki; Tomohiro Kubo; Tsuyoshi Hayashi; Tsutomu Sato; Yasushi Sato; Rishu Takimoto; Junji Kato
Journal:  J Gastroenterol       Date:  2013-01-19       Impact factor: 7.527

5.  Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion.

Authors:  Pablo Quintero; Margarita Pizarro; Nancy Solís; Juan Pablo Arab; Oslando Padilla; Arnoldo Riquelme; Marco Arrese
Journal:  J Physiol Biochem       Date:  2014-05-10       Impact factor: 4.158

Review 6.  Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.

Authors:  Alessandro Federico; Claudio Zulli; Ilario de Sio; Anna Del Prete; Marcello Dallio; Mario Masarone; Carmela Loguercio
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

7.  Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates.

Authors:  Su-Wen Jiang; Li-Peng Yao; Ai-Rong Hu; Yao-Ren Hu; Shi-Xiang Chen; Tao Xiong; Guo-Sheng Gao; Xiao-Yue Liang; Shi-Xiong Ding; Peng-Jian Weng
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 8.  Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.

Authors:  Ludovico Abenavoli; Natasa Milic; Valentina Peta; Francesco Alfieri; Antonino De Lorenzo; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD.

Authors:  Mohamed Abdalla Salman; Ahmed Abdallah Salman; Ahmed Abdelsalam; Mohamed Atallah; Hossam El-Din Shaaban; Ahmed El-Mikkawy; Mahmoud Gouda Omar; Mai Elshenoufy
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

10.  Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice.

Authors:  In Hee Kim; Jun Xu; Xiao Liu; Yukinori Koyama; Hsiao-Yen Ma; Karin Diggle; Young-Hyun You; Jan M Schilling; Dilip Jeste; Kumar Sharma; David A Brenner; Tatiana Kisseleva
Journal:  Age (Dordr)       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.